- Published at
- by marketscreener.com
neutral
neutral
DD: Dermapharm Holding SE
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
11.06.2024 / 10:00...
News for Dermapharm Holding SE (DMP.DE)
- Published at
- by marketscreener.com
positivepositiveDermapharm : COUNTERMOTION THEMIS BETEILIGUNGS-AKTIENGESELLSCHAFT
Begründung Der von der Verwaltung bekannt gemachte Beschlussvorschlag enthält einen Zahlendreher. Der im festgestellten Jahresabschluss...- Published at
- by marketscreener.com
positivepositiveDERMAPHARM : Buy rating from Berenberg -October 19, 2023 at 09:29 am EDT
Gerhard Orgonas from Berenberg retains his positive opinion on the stock with a Buy rating. The target price remains set at EUR 58.- Published at
- by prnewswire.com
mixedmixedEnlightened Growth Leadership Awards, 2023: Driving Change in Sustainability
/PRNewswire/ -- The Frost & Sullivan Institute is thrilled to present the highly anticipated 2023 Enlightened Growth Leadership Awards, an esteemed recognition...- Published at
- by marketscreener.com
positivepositiveDERMAPHARM : Berenberg maintains a Buy rating -September 21, 2023 at 02:18 am EDT
In a research note published by Gerhard Orgonas, Berenberg advises its customers to buy the stock. The target price is still set at EUR 58.- Published at
- by marketscreener.com
positivepositiveDERMAPHARM : Jefferies keeps its Buy rating -Today at 05:39 am
Alexander Thiel from Jefferies retains his positive opinion on the stock with a Buy rating. The target price is unchanged and still at EUR 65.- Published at
- by marketscreener.com
positivepositiveDermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall -Today at 01:32 am
EQS-News: Dermapharm Holding SE / Key word: Half Year Results/Half Year Report Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023...- Published at
- by globenewswire.com
neutralneutralAllergy Immunotherapy Market Size to Surpass USD 3.20 Billion in 2030, exhibiting a CAGR of 9.5%
As per the report by Fortune Business Insights, The global allergy immunotherapy market size was valued at USD 1.58 billion in 2022. The market is...- Published at
- by marketscreener.com
positivepositiveDermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQS-News: Dermapharm Holding SE / Key word: AGM/EGM/Dividend Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share 14.06.2023 / 17:00... | June 14, 2023- Published at
- by prnewswire.com
mixedmixedBrain health supplements market to grow by USD 4,020.62 million from 2022 to 2027; Growth driven by increase in the geriatric population - Technavio
/PRNewswire/ -- The brain health supplements market size is forecast to increase by USD 4,020.62 million from 2022 to 2027, at a CAGR of 8.18%, according to...- Published at
- by prnewswire.com
positivepositiveGlobal CBD Skin Care Market Size Anticipated To Reach $3.4 Billion By 2026, With A CAGR Of 24.80%
/PRNewswire/ -- FinancialNewsMedia.com News Commentary - The rise in consumer knowledge toward CBD infused FMCG product and ready product availability is...- Published at
- by marketscreener.com
neutralneutralU.S. CDC SAYS ADMINISTERED 50,641,884 DOSES OF COVID-19 VACCINE AS OF FEB. 13 VS 48,410,558 DOSES ADMINISTERED AS OF FEB. 12
U.S. CDC SAYS ADMINISTERED 50,641,884 DOSES OF COVID-19 VACCINE AS OF FEB. 13 VS 48,410,558 DOSES ADMINISTERED AS OF FEB. 12 ...- Published at
- by marketscreener.com
neutralneutralU.S. CDC SAYS DELIVERED 69,883,625 DOSES OF COVID-19 VACCINE AS OF FEB. 13 VS 69,014,725 DOSES DELIVERED AS OF FEB. 12
U.S. CDC SAYS DELIVERED 69,883,625 DOSES OF COVID-19 VACCINE AS OF FEB. 13 VS 69,014,725 DOSES DELIVERED AS OF FEB. 12 ...- Published at
- by marketscreener.com
mixedmixedEMA EXPECTS JOHNSON & JOHNSON TO FILE FOR APPROVAL OF ITS COVID-19 VACCINE IN THE NEXT FEW DAYS - COVID-19 TASK FORCE HEAD
EMA EXPECTS JOHNSON & JOHNSON TO FILE FOR APPROVAL OF ITS COVID-19 VACCINE IN THE NEXT FEW DAYS - COVID-19 TASK FORCE HEAD ...- Published at
- by marketscreener.com
neutralneutralEU DRUGS REGULATOR EMA PLANS ACCELERATED ASSESSMENTS OF COVID-19 VACCINES MODIFIED FOR VIRUS VARIANTS - COVID-19 TASK FORCE HEAD
EU DRUGS REGULATOR EMA PLANS ACCELERATED ASSESSMENTS OF COVID-19 VACCINES MODIFIED FOR VIRUS VARIANTS - COVID-19 TASK FORCE HEAD ...- Published at
- by marketscreener.com
neutralneutralGOOGLE'S DEAL INCLUDES PAYMENT OF $10 MLN IN EXCHANGE FOR ENDING PRESENT AND FUTURE COMPLAINTS FROM PUBLISHERS - DOCUMENTS
EXCLUSIVE-GOOGLE'S DEAL INCLUDES PAYMENT OF $10 MLN IN EXCHANGE FOR ENDING PRESENT AND FUTURE COMPLAINTS FROM PUBLISHERS - DOCUMENTS ...- Published at
- by marketscreener.com
neutralneutralALPHABET'S GOOGLE AGREES TO PAY $76 MLN OVER THREE YEARS TO GROUP OF FRENCH NEWS PUBLISHERS TO END COPYRIGHT SPAT - DOCUMENTS
EXCLUSIVE-ALPHABET'S GOOGLE AGREES TO PAY $76 MLN OVER THREE YEARS TO GROUP OF FRENCH NEWS PUBLISHERS TO END COPYRIGHT SPAT - DOCUMENTS ...- Published at
- by marketscreener.com
neutralneutralCANADA IS LOOKING AT POSSIBLY GETTING EXTRA VACCINES FROM INDIA - PM TRUDEAU
CANADA IS LOOKING AT POSSIBLY GETTING EXTRA VACCINES FROM INDIA - PM TRUDEAU ...- Published at
- by marketscreener.com
neutralneutralIMF'S GEORGIEVA SAYS IN TWEET THAT G7 SHOWED 'FULL ALIGNMENT' ON VACCINE ACCESS, GOVT RECOVERY SUPPORT, CLIMATE, SUPPORT FOR VULNERABLE COUNTRIES
IMF'S GEORGIEVA SAYS IN TWEET THAT G7 SHOWED 'FULL ALIGNMENT' ON VACCINE ACCESS, GOVT RECOVERY SUPPORT, CLIMATE, SUPPORT FOR VULNERABLE COUNTRIES ...- Published at
- by marketscreener.com
neutralneutralKAPLAN SAYS ONCE WE'VE WEATHERED THE PANDEMIC IT WOULD BE HEALTHIER TO START WEANING ASSET PURCHASES
KAPLAN SAYS ONCE WE'VE WEATHERED THE PANDEMIC IT WOULD BE HEALTHIER TO START WEANING ASSET PURCHASES ...